About Us
Connecting to Asian Air Sensors...
Research Watch
How H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child AbuseNew Study Highlights Metabolism Risks in Combination Antidepressant Therapy in NepalNew Study Reveals Hidden Environmental Drivers Behind Nepal’s Ongoing Cholera BattleThe Silent Pandemic: Kathmandu’s Poultry Industry Is Breeding Untreatable SuperbugsHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child AbuseNew Study Highlights Metabolism Risks in Combination Antidepressant Therapy in NepalNew Study Reveals Hidden Environmental Drivers Behind Nepal’s Ongoing Cholera BattleThe Silent Pandemic: Kathmandu’s Poultry Industry Is Breeding Untreatable Superbugs
Research Watch

How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities

ByLiza Nagarkoti, B.Sc. Nursing, M.A. Food & NutritionHealth Officer & Clinical Researcher
Published May 16, 2026Updated May 16, 2026

 In the rugged, breathtaking landscape of Nepal’s Karnali Province, where the peaks of Jumla reach toward the heavens, a silent health crisis is simmering within the digestive tracts of its residents. While the world often focuses on the physical toll of climbing these heights, a team of researchers has turned their attention to a microscopic invader that is far more persistent than any mountain trail: Helicobacter pylori.

A recent study published in the Janaki Medical College Journal of Medical Sciences by Professor Dharma Datta Subedi and colleagues sheds a bright light on the "Status of helicobacter pylori infection and its impact on peptic ulcer disease in high-altitude in Karnali Province". As a health reporter tracking the unique medical challenges of mountainous regions, I’ve found that this research offers more than just data; it provides a window into how geography, poverty, and biology collide at 2,500 to 3,500 meters above sea level.

The High-Altitude Context

Life at high altitude is not just about thin air; it’s about a physiological battle. The study, conducted at the Karnali Academy of Health Sciences (KAHS) in Jumla, notes that environments above 2,500 meters subject the human body to chronic hypoxic stress. This lack of oxygen doesn't just make you winded; it can actually weaken the lining of the stomach, reducing blood flow and protective secretions, which makes the gut far more vulnerable to infection and ulceration.

Coupled with this biological vulnerability are the harsh realities of life in remote Nepal: limited access to clean water, poor sanitation, and a healthcare system that is often miles of difficult terrain away. It is in this specific setting that the researchers sought to understand why so many people in Karnali suffer from chronic stomach pain and indigestion.

A Closer Look at the Study

The researchers spent a full year (from late 2021 to late 2022) examining 143 adult patients who visited the outpatient department at KAHS complaining of dyspepsia—what we commonly know as persistent indigestion or upper abdominal pain. These weren't just random individuals; they were people genuinely suffering from suspected acid-related diseases.

To get a clear picture, the team didn't rely on just one test. They used a "triple-threat" diagnostic approach: blood tests to look for antibodies (serology), stool antigen tests to find active infections, and endoscopic biopsies where a tiny piece of tissue is taken directly from the stomach lining.

The Numbers: A Stark Reality

The findings were, frankly, staggering. The study revealed that 86.7% of the patients were infected with H. pylori. To put that in perspective, while about half of the global population carries this bacterium, the prevalence in high-altitude Karnali is significantly higher than the 40–70% typically reported in other parts of Nepal.

What’s even more concerning is who is being hit the hardest. The "sweet spot" for this infection seems to be the 31-45 age group, which made up over 41% of the participants. These are people in their most economically productive years—the farmers and labourers who are the backbone of the Karnali economy.

The researchers found a clear link between lifestyle and the disease:

a.    Occupation: 58% of the infected were involved in agriculture.

b.    Income: Over 66% came from low-income backgrounds.

c.     Diet: Nearly 59% admitted to having irregular food habits, which can disrupt the stomach's natural acid cycles and give the bacteria a foothold.

From Infection to Injury: The Peptic Ulcer Link

The bacteria aren't just an uninvited guest; it’s a destructive one. The study used endoscopy, literally a camera in the stomach, to see the damage. They found that 56% of the patients had visible ulcers or erosions.

The most common victim was the duodenum (the first part of the small intestine), particularly the "duodenal bulb," where 45.5% of ulcers were located. This is classic H. pylori behaviour. The bacteria also targeted the antrum, the lower part of the stomach, in about 35.7% of cases.

Perhaps most worrying for the long term was the discovery of gastric malignancy (stomach cancer) in 2.8% of the cases. While this number seems low, the researchers warn that in high-altitude areas, the combination of chronic inflammation from H. pylori and the stress of hypoxia can actually speed up the road to cancer.

The Age Factor: A Diagnostic Puzzle

One of the most interesting nuances of the study is how the infection looks different as we age.

a.    The Young (16-30): Most were positive via blood tests (82.9%), but had zero biopsy-confirmed cases. This suggests that younger people might be in the early stages of infection or have had it in the past.

b.    The Middle-Aged (31-55): This group showed the most "active" infections, with higher rates of positive stool and biopsy tests. They are the ones currently suffering the most severe symptoms.

c.     The Elderly (56+): Interestingly, the rates of H. pylori seemed to decline or become harder to detect in older patients. The researchers suggest this could be because the bacteria actually have a harder time surviving in a stomach that has become too damaged over decades, or perhaps these older patients are suffering from ulcers caused by other things, like the frequent use of painkillers (NSAIDs) for joint pain.

Why Does This Matter?

The implications of this study are profound for the people of Karnali. For a long time, stomach pain was perhaps seen as just a part of a hard life in the mountains. But this research proves it is a manageable infectious disease that is being exacerbated by the environment.

The researchers are calling for a "context-specific" approach to health in the highlands. We cannot simply use the same diagnostic strategies in Jumla that we use in Kathmandu. Because blood tests can sometimes reflect old infections rather than current ones, the study suggests that stool antigen tests and biopsies are critical for getting an accurate diagnosis in middle-aged patients who are at high risk.

The Path Forward

We need to stop treating the symptoms and start treating the source. The study highlights an urgent need for:

a.    Screening Programs: Especially for those in high-risk groups like farmers and low-income families.

b.    Education: Teaching the importance of regular mealtimes and hand hygiene to prevent the "fecal-oral" transmission of bacteria.

c.     Better Access: Bringing advanced diagnostics like endoscopy and reliable stool testing to remote centers so that people don't have to wait until they have a bleeding ulcer or cancer to get help.

The mountains of Karnali are beautiful, but for the people living there, the air is thin and the gut is vulnerable. This study is a call to action for the government and health agencies to recognize that in Nepal's high-altitude regions, the fight against H. pylori is a fight for the very livelihood of the community.

By recognizing that nearly 9 out of 10 symptomatic patients in this region carry this bacterium, we can finally begin to provide the targeted, life-changing treatment they deserve.

References (26)
  1. Subedi, D. D., Giri, R. M., & Bam, N. (2026). Status of helicobacter pylori infection and its impact on peptic ulcer disease in high-altitude in Karnali Province. Janaki Medical College Journal of Medical Sciences, 14(1), 18–29.
  2. Cited References within the Study
  3. Suerbaum, S., & Michetti, P. (2002). Helicobacter pylori infection. New England Journal of Medicine, 347(15), 1175–1186.
  4. Blaser, M. J., & Atherton, J. C. (2004). Helicobacter pylori persistence: Biology and disease. Journal of Clinical Investigation, 113(3), 321–333.
  5. Hooi, J. K. Y., Lai, W. Y., Ng, W. K., et al. (2017). Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology, 153(2), 420–429.e10.
  6. Shrestha, R., Shrestha, S., Acharya, P., & Shrestha, A. (2012). Prevalence of Helicobacter pylori in dyspeptic patients at Kathmandu Medical College. Journal of Kathmandu Medical College, 1(2), 85–89.
  7. Zhang, Z., Xu, J., & Shen, Y. (2001). Changes of gastric mucosal barrier and mucosal immunity at high altitude. Chinese Journal of Internal Medicine, 40(9), 617–620.
  8. Karnali Academy of Health Sciences. (2026, May 2). Karnali Academy of Health Sciences. https://kahs.edu.np
  9. Fashner, J., & Gitu, A. C. (2015). Diagnosis and treatment of peptic ulcer disease and Helicobacter pylori infection. American Family Physician, 91(4), 236–242.
  10. Ahmed, N., et al. (2017). Socioeconomic status and risk of Helicobacter pylori infection. PLoS One, 12(11), e0187453.
  11. Malfertheiner, P., et al. (2017). Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut, 66(1), 6–30.
  12. Pandey, A., et al. (2010). Health inequities in caste-based social groups in India. Indian Journal of Medical Research, 131, 28–33.
  13. Singh, S., Adhikari, S., Varshney, N., Rani, C., Kumar, A., Kumar, R., & Jha, H. C. (2025). Overcoming antimicrobial resistance in Helicobacter pylori: The roles of collateral sensitivity and biofilm dynamics. Journal of Antimicrobial Chemotherapy, 80(7), dkaf233.
  14. Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017). ACG clinical guideline: Treatment of Helicobacter pylori infection. American Journal of Gastroenterology, 112(2), 212–239.
  15. Goodman, K. J., & Correa, P. (2000). Transmission of Helicobacter pylori among siblings. American Journal of Gastroenterology, 95(7), 1806–1811.
  16. Hestvik, E., et al. (2010). Helicobacter pylori in Africa: A systematic review. PLoS One, 5(11), e13178.
  17. Malfertheiner, P., Schulz, C., & Hunt, R. H. (2024). Helicobacter pylori infection: A 40-year journey through shifting the paradigm to transforming the management. Digestive Diseases, 42(4), 299–308.
  18. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001). Helicobacter pylori infection and the development of gastric cancer. New England Journal of Medicine, 345(11), 784–789.
  19. Kuipers, E. J., Klinkenberg-Knol, E. C., & Meuwissen, S. G. (1999). Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease. Yale Journal of Biology and Medicine, 72(2-3), 211.
  20. Liou, J. M., Lee, Y. C., & Wu, M. S. (2020). Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota. Journal of Gastroenterology and Hepatology, 35(7), 1107–1116.
  21. Chey, W. D., & Wong, B. C. Y. (2007). The management of Helicobacter pylori infection. American Journal of Gastroenterology, 102(8), 1808–1825.
  22. Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022). ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 117(1), 27–56.
  23. McColl, K. E. L. (2010). Helicobacter pylori. New England Journal of Medicine, 362(17), 1597–1604.
  24. Ramos, A. R., Alayo, E. C., Requena, D. M., Casella, J. L., Castro, M. C., & Otoya, C. (2003). Changes in the prevalence of Helicobacter pylori in Peru during 1985-2002. Revista de Gastroenterología del Perú, 23(2), 92–98.
  25. Soto, G., Bautista, C. T., Roth, D. E., Gilman, R. H., Velapatiño, B., Ogura, M., et al. (2003). Helicobacter pylori reinfection is common in Peruvian adults after eradication therapy. Journal of Infectious Diseases, 188(9), 1263–1275.
  26. Hinninghofen, H., Musial, F., Kowalski, A., & Enck, P. (2006). Gastric emptying effects of dietary fiber during 8 hours at two simulated cabin altitudes. Aviation, Space, and Environmental Medicine, 77(2), 121–123.

Share this article

About the Author
Written By
Liza Nagarkoti
Liza Nagarkoti, B.Sc. Nursing, M.A. Food & Nutrition
Health Officer & Clinical Researcher

Specializing in Emergency Care, Maternal Health, and Therapeutic Nutrition

Full Bio & Articles

Related Content

🌿

Blyss

Your Health Guide · The Health Thread

🌿
Hi, I'm Blyss 🌿 Your personal health guide on The Health Thread. I can help you find articles, tools, and health resources. How can I help you today?

⚕️ Not medical advice. Always consult a qualified doctor.